95 results
Page 3 of 5
8-K
EX-99.1
hga6m912nhzusm9qq7
4 Aug 20
Invitae Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples Accessioned in the Second Quarter of 2020
4:13pm
424B5
pz52hnva i805wapph8
3 Apr 20
Prospectus supplement for primary offering
12:00am
424B5
i0nimlhi
1 Apr 20
Prospectus supplement for primary offering
5:05pm
8-K
xe75d8yo67iktt
1 Apr 20
Regulation FD Disclosure
4:39pm
8-K
t2ircwv6
1 Apr 20
Invitae Announces Proposed Public Offering of Common Stock
4:34pm
8-K
EX-99.1
m9u nngnyemnouc41k2
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
28wid7wqi1u or8kv
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
EX-99.2
1l30 59g04neoh66uqd
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
EX-99.1
u2ttz1ch
13 Nov 19
Invitae to Acquire Clear Genetics
4:09pm
8-K
7bkvn30 5if5r2ldl
13 Nov 19
Invitae to Acquire Clear Genetics
4:09pm
8-K
EX-99.1
clnuyratvtwb qy30273
6 Nov 19
Invitae Reports $56.5 Million in Quarterly Revenue Driven by 129,000 Samples
4:08pm
8-K
EX-99.1
6yk31xbgap
6 Aug 19
Invitae Reports $53.5 Million in Quarterly Revenue Driven by More Than 111,000 Samples in Quarterly Volume
4:17pm